Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Endocrinology

Welcome to the HHRH Community: A Starting Guide

At a Glance

HHRH is a rare inherited disorder caused by SLC34A3 changes that make the kidneys waste phosphate and release too much calcium into urine. Care balances phosphate replacement for bone health with hydration and monitoring to reduce the risk of kidney stones and calcium deposits in the kidneys.

Receiving a diagnosis of Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) often marks the end of a long “diagnostic odyssey” for many families. Because this condition is an ultra-rare disease—with an estimated prevalence of roughly 1 in 250,000 people—most local doctors and even many specialists may have never seen a case before [1][2]. You may find yourself becoming the resident expert on the condition, navigating a complex path that involves both bone health and kidney function. While primarily diagnosed in childhood, some individuals are not correctly diagnosed until adulthood when they experience recurrent fractures or kidney stones.

Understanding HHRH

HHRH is a genetic disorder that affects how the body manages phosphate and calcium. It is caused by changes (mutations) in the SLC34A3 gene, which provides instructions for a “transporter” protein in the kidneys [3]. This transporter is responsible for reclaiming phosphate from the urine and putting it back into the bloodstream.

In HHRH, this transporter does not work correctly, leading to two primary issues:

  1. Phosphate Wasting: The kidneys lose too much phosphate in the urine (phosphaturia). Without enough phosphate in the blood (hypophosphatemia), bones cannot harden properly, leading to rickets (softening and weakening of bones in children) or osteomalacia (bone softening in adults) [1][4].
  2. Calcium Excretion: Due to the way the body tries to compensate for low phosphate, it produces high levels of its own active vitamin D (1,25-dihydroxyvitamin D). This causes the gut to absorb extra calcium, and the kidneys to release more calcium into the urine (hypercalciuria) [1][3].

A Dual-System Challenge

HHRH is unique because it is a “dual-system” disease. While many forms of rickets only require focusing on the bones, HHRH families must carefully balance the health of the skeleton with the health of the kidneys.

  • Bone Health: Symptoms often include leg bowing, bone pain, slow growth, and an increased risk of fractures [5][6].
  • Kidney Health: High levels of calcium in the urine put patients at increased risk for nephrolithiasis (kidney stones) and nephrocalcinosis (calcium deposits in the kidney tissue). In some study cohorts, approximately half of individuals with HHRH developed one of these kidney complications over time, though individual risk varies [1][4].

Managing HHRH requires a delicate dance: providing enough phosphate to heal the bones without worsening the calcium levels in the urine, which could stress the kidneys.

Navigating the Emotional Impact

Caring for a child—or living as an adult—with an ultra-rare disease brings significant practical and emotional weight. It is normal to feel:

  • Isolation: Because the disease is so rare, finding other families who truly understand your daily reality can be difficult [7].
  • Genetic Guilt: Since HHRH is an autosomal recessive condition (meaning a child usually inherits one mutated gene from each parent), parents sometimes experience guilt. It is vital to remember that this is nobody’s fault; we cannot control the genes we pass down [8][9]. A genetic counselor can help explain recurrence risks for future pregnancies.
  • Healthcare Fatigue: Coordinating between multiple specialists—such as endocrinologists (hormone and bone specialists) and nephrologists (kidney specialists)—can feel like a full-time job [10][11].

What to Expect After Diagnosis

Once HHRH is confirmed through genetic testing, care will shift toward stabilizing chemistry and protecting growth.

  • Specialized Care: You will likely work with a multidisciplinary team. It is common to have regular appointments for blood work and urine tests to monitor phosphate, calcium, and vitamin D levels [5][12].
  • Imaging: Periodic renal ultrasounds are utilized to check for kidney stones or calcium deposits [5][13].
  • Treatment Differences: It is crucial to know that HHRH is treated differently than more common types of rickets. For example, in HHRH, active vitamin D analogs (like calcitriol) are avoided because they can dangerously increase calcium in the urine [1][14].
  • Family Screening: Because HHRH is genetic, doctors may recommend testing siblings or checking parents, as carriers of a single mutation can sometimes still be prone to kidney stones [15][16].

Everyday Lifestyle Note
Do not attempt to restrict dietary calcium to prevent kidney stones unless specifically instructed by your nephrologist; doing so can actually harm the bones further. Aim for a normal, age-appropriate calcium intake. Maintaining excellent daily hydration (drinking plenty of water) is one of the most effective ways to reduce the risk of kidney stones. Never alter phosphate doses on your own.

You are your own (or your child’s) most important advocate. A clear understanding of this bone-kidney connection is the first step in protecting long-term health.

Common questions in this guide

What is HHRH, and what causes it?
Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a rare inherited disorder caused by changes in the SLC34A3 gene. The kidneys waste too much phosphate and put extra calcium into the urine, which can affect bone strength and kidney health.
What symptoms and complications can HHRH cause?
HHRH can cause leg bowing, bone pain, slow growth, and fractures because low phosphate prevents bones from hardening normally. High calcium in the urine can lead to kidney stones or nephrocalcinosis, which means calcium deposits in kidney tissue.
How is HHRH managed after diagnosis?
Care usually includes phosphate treatment, regular blood and urine tests, and follow-up of growth, leg alignment, and bone health. Kidney ultrasounds may be used to look for stones or calcium deposits, and treatment must balance bone healing with kidney protection.
Why are active vitamin D medicines often avoided in HHRH?
HHRH can already cause high active vitamin D and increased calcium absorption, raising calcium levels in the urine. Medicines such as calcitriol may therefore worsen the risk of kidney stones or kidney calcium deposits, so clinicians often avoid them and monitor nutritional vitamin D separately.
Should people with HHRH limit calcium or change their phosphate dose?
People with HHRH should not restrict dietary calcium unless their nephrologist specifically recommends it, because too little calcium can further harm bone health. Do not change phosphate doses on your own; follow the plan from the treating team and ask about age-appropriate calcium and hydration goals.
Should relatives be tested for HHRH?
Because HHRH is usually inherited when a child receives an altered gene from each parent, clinicians may recommend genetic testing for siblings or evaluation of parents. A genetic counselor can explain carrier results, possible kidney-stone risk in some carriers, and recurrence risks for future pregnancies.

Get notified when new evidence is published on Hereditary hypophosphatemic rickets with hypercalciuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy.

    Bergwitz C, Miyamoto KI

    Pflugers Archiv : European journal of physiology 2019; (471(1)):149-163 doi:10.1007/s00424-018-2184-2.

    PMID: 30109410
  2. 2

    Hereditary Hypophosphatemic Rickets with Hypercalciuria-Importance of Further Evaluation when Clinical Suspicion is Strong

    Wettasinghe CA, Kumarasiri IM, Vidushajini M, et al.

    Journal of clinical research in pediatric endocrinology 2026; (18(3)):549-553 doi:10.4274/jcrpe.galenos.2025.2025-1-15.

    PMID: 40820604
  3. 3

    Renal phosphate handling and inherited disorders of phosphate reabsorption: an update.

    Wagner CA, Rubio-Aliaga I, Hernando N

    Pediatric nephrology (Berlin, Germany) 2019; (34(4)):549-559 doi:10.1007/s00467-017-3873-3.

    PMID: 29275531
  4. 4

    An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).

    Zhu Z, Bo-Ran Ho B, Chen A, et al.

    Kidney international 2024; (105(5)):1058-1076 doi:10.1016/j.kint.2024.01.031.

    PMID: 38364990
  5. 5

    Rickets guidance: part II-management.

    Haffner D, Leifheit-Nestler M, Grund A, Schnabel D

    Pediatric nephrology (Berlin, Germany) 2022; (37(10)):2289-2302 doi:10.1007/s00467-022-05505-5.

    PMID: 35352187
  6. 6

    Variable Clinical Presentation of Children with Hereditary Hypophosphatemic Rickets with Hypercalciuria: A Case Series and Review of the Literature.

    Christensen S, Tebben PJ, Sas D, Creo AL

    Hormone research in paediatrics 2021; (94(9-10)):374-389 doi:10.1159/000520299.

    PMID: 34666334
  7. 7

    Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective.

    Pignolo RJ, Bedford-Gay C, Cali A, et al.

    Orphanet journal of rare diseases 2022; (17(1)):168 doi:10.1186/s13023-022-02224-w.

    PMID: 35436894
  8. 8

    Carer burden in rare inherited diseases: a literature review and conceptual model.

    Sandilands K, Williams A, Rylands AJ

    Orphanet journal of rare diseases 2022; (17(1)):428 doi:10.1186/s13023-022-02561-w.

    PMID: 36494728
  9. 9

    HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA: A NOVEL HOMOZYGOUS MUTATION IN SLC34A3 AND LITERATURE REVIEW.

    Bhadada SK, Sridhar S, Dhiman V, et al.

    AACE clinical case reports 2020; (6(3)):e105-e112 doi:10.4158/ACCR-2019-0456.

    PMID: 32524022
  10. 10

    Rare inherited disorders with renal involvement-approach to the patient.

    Joly D, Béroud C, Grünfeld JP

    Kidney international 2015; (87(5)):901-8 doi:10.1038/ki.2014.432.

    PMID: 25651365
  11. 11

    Whole Body, Whole Life, Whole Family: Patients' Perspectives on X-Linked Hypophosphatemia.

    Hamilton AA, Faitos S, Jones G, et al.

    Journal of the Endocrine Society 2022; (6(8)):bvac086 doi:10.1210/jendso/bvac086.

    PMID: 35860754
  12. 12

    Multidisciplinary patient care in X-linked hypophosphatemic rickets: one challenge, many perspectives.

    Raimann A, Mindler GT, Kocijan R, et al.

    Wiener medizinische Wochenschrift (1946) 2020; (170(5-6)):116-123 doi:10.1007/s10354-019-00732-2.

    PMID: 31993875
  13. 13

    SLC34A3 GENE MUTATION AS A RARE CAUSE OF HYPOPHOSPHATEMIA IN TWO SIBLINGS.

    Karakilic-Ozturan E, Ozturk AP, Oney C, et al.

    Acta endocrinologica (Bucharest, Romania : 2005) 2022; (18(3)):387-391 doi:10.4183/aeb.2022.387.

    PMID: 36699160
  14. 14

    Phosphate matters when investigating hypercalcemia: a mutation in SLC34A3 causing HHRH

    Tang AR, Hinz LE, Khan A, Kline GA

    Endocrinology, diabetes & metabolism case reports 2019; (2019(1)):1-6 doi:10.1530/EDM-19-0058.

    PMID: 31352694
  15. 15

    SLC34A3 Intronic Deletion in an Iranian Kindred with Hereditary Hypophosphatemic Rickets with Hypercalciuria

    Hasani-Ranjbar S, Ejtahed HS, Amoli MM, et al.

    Journal of clinical research in pediatric endocrinology 2018; (10(4)):343-349 doi:10.4274/jcrpe.0057.

    PMID: 29809158
  16. 16

    [Clinical feature and variant analysis of a case with hereditary hypophosphatemic rickets with hypercalciuria].

    Liu L, Gao X, Ma Y, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(6)):637-640 doi:10.3760/cma.j.issn.1003-9406.2020.06.010.

    PMID: 32472541

This HHRH starting guide is for informational purposes only and does not constitute medical advice. Your endocrinology, nephrology, and genetics team should tailor phosphate, calcium, vitamin D, hydration, and monitoring plans to your situation.